| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.486 | 7.154 | 7.846 | 7.160 | 8.941 | 9.132 | 36.631 | 9.370 | 9.342 | 10.755 |
| Total Income - EUR | 5.486 | 7.154 | 8.243 | 7.161 | 8.941 | 9.396 | 38.408 | 9.375 | 9.347 | 11.762 |
| Total Expenses - EUR | 3.934 | 4.832 | 8.705 | 5.264 | 7.191 | 4.675 | 3.740 | 6.609 | 6.589 | 11.060 |
| Gross Profit/Loss - EUR | 1.553 | 2.323 | -462 | 1.896 | 1.751 | 4.721 | 34.668 | 2.766 | 2.757 | 702 |
| Net Profit/Loss - EUR | 1.388 | 2.108 | -709 | 1.681 | 1.482 | 4.522 | 33.869 | 2.540 | 2.532 | 349 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Rosianu Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.139 | 3.916 | 1.725 | 847 | 0 | 0 | 752 | 647 | 646 | 449 |
| Current Assets | 8.080 | 12.436 | 3.837 | 6.350 | 3.298 | 6.581 | 34.256 | 6.862 | 6.841 | 6.536 |
| Inventories | 1.551 | 2.618 | 1.751 | 3.094 | 2.490 | 4.043 | 3.457 | 2.713 | 2.705 | 2.689 |
| Receivables | 409 | 289 | 311 | 284 | 414 | 23 | 3.459 | 664 | 662 | 633 |
| Cash | 6.119 | 9.529 | 1.775 | 2.972 | 394 | 2.515 | 27.340 | 3.486 | 3.475 | 3.214 |
| Shareholders Funds | -7.981 | -5.792 | -6.393 | -4.594 | -3.024 | 1.555 | 35.389 | 3.566 | 3.556 | 542 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 24.976 | 24.732 | 14.344 | 13.981 | 8.319 | 5.070 | 1.281 | 5.393 | 5.377 | 7.880 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 1.804 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Rosianu Med S.r.l.